(Q40476247)

20 September 2017

title

Appropriateness of antiviral prescribing for influenza in primary care: a retrospective analysis. (English)

1 reference

20 September 2017

Linder JA

1

1 reference

20 September 2017

Chan JC

series ordinal

2

1 reference

20 September 2017

Bates DW

series ordinal

3

1 reference

20 September 2017

publication date

1 June 2006

1 reference

Journal of Clinical Pharmacy and Therapeutics

20 September 2017

published in

1 reference

20 September 2017

volume

31

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

245-252

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Prevention and treatment of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Economic analysis of influenza vaccination and antiviral treatment for healthy working adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Management of influenza symptoms in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Cost-effectiveness of newer treatment strategies for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Changing use of antibiotics in community-based outpatient practice, 1991-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Clinical signs and symptoms predicting influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations--a questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Antiviral therapy of influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Trends in antimicrobial prescribing rates for children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

The predictive value of influenza symptomatology in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Predicting influenza infections during epidemics with use of a clinical case definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Clinical features of influenza A virus infection in older hospitalized persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2006.00731.X

10.1111/J.1365-2710.2006.00731.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference